Chao‐Yi Huang

Splenomegaly in predicting the survival of patients with advanced primary liver cancer treated with immune checkpoint inhibitors

Lushan Xiao, Chengyi Hu, Hao Cui et al. · Cancer Medicine · 2022 · 32 citations · Full text

Medicine, Immunology, Oncology +17

Use of computed tomography-derived body composition to determine the prognosis of patients with primary liver cancer treated with immune checkpoint inhibitors: a retrospective cohort study

Lushan Xiao, Rui-ning Li, Hao Cui et al. · BMC Cancer · 2022 · 28 citations · Full text

Medicine, Oncology, Radiology +17

Lung metastasis and lymph node metastasis are risk factors for hyperprogressive disease in primary liver cancer patients treated with immune checkpoint inhibitors

Lushan Xiao, Qimei Li, Chengyi Hu et al. · Annals of Palliative Medicine · 2021 · 23 citations · Full text

Medicine, Oncology, Immunotherapy +16